胶质母细胞瘤(glioblastoma, GBM) 因组织学异质性, 侵袭能力强, 术后复发快等问题,
致使患者经手术治疗, 化疗和放疗后的预后差, 总体生存期短. GBM 细胞来源外泌体(GBM cell …

Patients with glioblastoma (GBM) generally have a bad prognosis and short overall survival
after being treated with surgery, chemotherapy or radiotherapy due to the histological …

Brain tumours are a serious concern among both physicians and patients. The most feared
brain tumour is glioblastoma (GBM) due to its heterogeneous histology, substantial invasive …

目的: 探讨胶质瘤干细胞(glioblastoma stem cell, GSC) 来源的外泌体(extracellular vesicle, EV)
对胶质瘤细胞的增殖, 侵袭和替莫唑胺(temozolomide, TMZ) 耐药能力的体内外影响. 方法 …

Exosomes constitute small extracellular vesicles that contain lipids, proteins, nucleic acids,
and glycoconjugates from the secreted cells and are capable of transmitting signals …

Introduction: Glioblastoma is the most common brain tumour with 15 month median survival
due to rapid recurrence and metastasis after initial treatment. Accumulating evidences …

Exosomes are small extracellular vesicles (EVs) that play a key role in cell-to-cell
communication. These small EVs are secreted by all cell types and are deeply involved in …

Glioblastoma belongs to the most aggressive type of cancer with a low survival rate that is
characterized by the ability in forming a highly immunosuppressive tumor microenvironment …

Glioblastoma multiforme (GBM) is a common, aggressive, fast‐growing tumor of the central
nervous system that currently has no effective treatment. Although stem cell therapy has …

Glioblastoma (GBM) is the most common and aggressive cancer of the brain. Presently,
GBM patients have a poor prognosis, and therapy primarily aims to extend the life …